Very Superstitious (English)
- New search for: Sekeres, M.A.
- New search for: Sekeres, M.A.
In:
JOURNAL OF CLINICAL ONCOLOGY
;
30
, 24
;
3026-3027
;
2012
-
ISSN:
- Article (Journal) / Print
-
Title:Very Superstitious
-
Contributors:Sekeres, M.A. ( author )
-
Published in:JOURNAL OF CLINICAL ONCOLOGY ; 30, 24 ; 3026-3027
-
Publisher:
- New search for: American Society of Clinical Oncology
-
Publication date:2012-01-01
-
Size:2 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.99
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.99 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 30, Issue 24
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 2963
-
Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine TumorsChan, J.A. / Stuart, K. / Earle, C.C. et al. | 2012
- 2969
-
Risk of Colorectal Cancer After Detection and Removal of Adenomas at Colonoscopy: Population-Based Case-Control StudyBrenner, H. / Chang-Claude, J. / Rickert, A. et al. | 2012
- 2977
-
Suppression of Plasma Estrogen Levels by Letrozole and Anastrozole Is Related to Body Mass Index in Patients With Breast CancerFolkerd, E.J. / Dixon, J.M. / Renshaw, L. et al. | 2012
- 2981
-
Improving Survival Trends in Primary Myelofibrosis: An International StudyCervantes, F. / Dupriez, B. / Passamonti, F. et al. | 2012
- 2988
-
Chlamydophila Psittaci Eradication With Doxycycline As First-Line Targeted Therapy for Ocular Adnexae Lymphoma: Final Results of an International Phase II TrialFerreri, A.J.M. / Govi, S. / Pasini, E. et al. | 2012
- 2995
-
Patterns of Survival Among Patients With Myeloproliferative Neoplasms Diagnosed in Sweden From 1973 to 2008: A Population-Based StudyHultcrantz, M. / Kristinsson, S.Y. / Andersson, T.M.-L. et al. | 2012
- 3002
-
First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer: The TORCH Randomized TrialGridelli, C. / Ciardiello, F. / Gallo, C. et al. | 2012
- 3012
-
The Price We Pay for Progress: A Meta-Analysis of Harms of Newly Approved Anticancer DrugsNiraula, S. / Seruga, B. / Ocana, A. et al. | 2012
- 3020
-
Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical OpinionBasch, E. / Oliver, T.K. / Vickers, A. et al. | 2012
- 3026
-
Very SuperstitiousSekeres, M.A. et al. | 2012
- 3028
-
Risk Factors for the Incidence of Second Cancers in Survivors of Retinoblastoma With a Family HistoryMoll, A.C. / Dommering, C.J. / Bosscha, M.I. et al. | 2012
- 3029
-
On the Prevalence and Causes of Oncologist BurnoutBlanchard, P. / Rodrigues, M. / Colombat, P. et al. | 2012
- 3031
-
Testing for Discordance at Metastatic Relapse of Breast Cancer Mattersvan Diest, P.J. / Hoefnagel, L.D.C. / van der Wall, E. et al. | 2012
- 3033
-
Polyclonal Serum Free Light Chains: A Biomarker of Disease Prognosis or of Immune Senescence?Bibas, M. et al. | 2012